Global High Throughput Screening Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global High Throughput Screening Market Research Report 2024
High-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Using robotics, data processing and control software, liquid handling devices, and sensitive detectors, High-Throughput Screening allows a researcher to quickly conduct millions of chemical, genetic or pharmacological tests.
According to MRAResearch’s new survey, global High Throughput Screening market is projected to reach US$ 16570 million in 2033, increasing from US$ 12010 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole High Throughput Screening market research.
Based on technology, the label-free technology segment is expected to grow at the highest CAGR during the forecast period. The major advantage offered by label-free technology is that it can help in the study of varied cell types and targets. Label-free assays also provide simple methods for studying complex biological pathways. The label-free technology is set to reduce drug failure caused by toxicity. These factors are likely to boost the growth of this technology market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global High Throughput Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher
Agilent Technologies
Danaher
Perkinelmer
Tecan Group
Axxam
Bio-Rad Laboratories
Merck
Hamilton
Corning Incorporated
Biotek Instruments
Aurora Biomed
Segment by Type
Cell-based Assays
Lab-On-A-Chip
Ultra-High-Throughput Screening
Bioinformatics
Label-Free Technology
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The High Throughput Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global High Throughput Screening market is projected to reach US$ 16570 million in 2033, increasing from US$ 12010 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole High Throughput Screening market research.
Based on technology, the label-free technology segment is expected to grow at the highest CAGR during the forecast period. The major advantage offered by label-free technology is that it can help in the study of varied cell types and targets. Label-free assays also provide simple methods for studying complex biological pathways. The label-free technology is set to reduce drug failure caused by toxicity. These factors are likely to boost the growth of this technology market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global High Throughput Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Agilent Technologies
Danaher
Perkinelmer
Tecan Group
Axxam
Bio-Rad Laboratories
Merck
Hamilton
Corning Incorporated
Biotek Instruments
Aurora Biomed
Segment by Type
Cell-based Assays
Lab-On-A-Chip
Ultra-High-Throughput Screening
Bioinformatics
Label-Free Technology
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The High Throughput Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source